News
Policy & Recommendations
CDC A(H5N1) Bird Flu Response Update May 24, 2024
USDA expands support for H5N1 response to more dairy producers
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Nirsevimab has been recently licensed for universal RSV prophylaxis in infants. NIRSE-GAL is a three-year population-based study initiated in Galicia in September 2023.
Influenza Viruses Remain Infectious in Unpasteurized Milk on Milking Machinery Surfaces
First case of influenza A (H5) detected in Michigan resident
Michigan reports a human case of bird flu, the nation’s second linked to H5N1 outbreak in dairy cows
Move over, wastewater. Store-bought milk could be another way to track the bird flu outbreak in cows
Article
News
Scientific Papers
US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses
What is the pandemic potential of avian influenza A(H5N1)?
On March 25, 2024, a national authority in Viet Nam notified WHO of a case of human infection with highly pathogenic avian influenza. Then on April 1, a second but unrelated human infection with (H5N1virus was reported in Texas, USA.
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Safe and effective vaccines against SARS-CoV-2 were developed in less than 1 year.
Wastewater testing finds H5N1 avian flu in 9 Texas cities
Researchers who sequenced viruses from wastewater samples from 10 Texas cities found H5N1 avian flu virus in 9 of them, sometimes at levels that rivaled seasonal flu.
